0001847903-24-000030.txt : 20240202
0001847903-24-000030.hdr.sgml : 20240202
20240202170203
ACCESSION NUMBER: 0001847903-24-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anderson Karen M.
CENTRAL INDEX KEY: 0001762176
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40445
FILM NUMBER: 24592518
MAIL ADDRESS:
STREET 1: C/O CENTESSA PHARMACEUTICALS PLC
STREET 2: 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM
CITY: CHESHIRE
STATE: X0
ZIP: WA14 2DT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Centessa Pharmaceuticals plc
CENTRAL INDEX KEY: 0001847903
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3RD FLOOR
STREET 2: 1 ASHLEY ROAD
CITY: ALTRINCHAM, CHESHIRE
STATE: X0
ZIP: WA14 2DT
BUSINESS PHONE: 44 7391 789784
MAIL ADDRESS:
STREET 1: 3RD FLOOR
STREET 2: 1 ASHLEY ROAD
CITY: ALTRINCHAM, CHESHIRE
STATE: X0
ZIP: WA14 2DT
FORMER COMPANY:
FORMER CONFORMED NAME: Centessa Pharmaceuticals Ltd
DATE OF NAME CHANGE: 20210224
4
1
wk-form4_1706911308.xml
FORM 4
X0508
4
2024-02-01
0
0001847903
Centessa Pharmaceuticals plc
CNTA
0001762176
Anderson Karen M.
C/O CENTESSA PHARMACEUTICALS PLC
3RD FL., 1 ASHLEY RD, ALTRINCHAM
CHESHIRE
X0
WA14 2DT
UNITED KINGDOM
0
1
0
0
Chief People Officer
0
Ordinary Shares
2024-02-01
4
A
0
31250
0
A
84950
D
Ordinary Shares
2024-02-01
4
F
0
7265
8.19
D
77685
D
Share Option (right to buy)
8.01
2024-02-01
4
A
0
125000
0
A
2034-02-01
Ordinary Shares
125000
125000
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 1, 2025.
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.
/s/ Gregory Weinhoff, attorney-in-fact
2024-02-02